Abbott Laboratories
ABTMedical Devices
$106.20+1.56%As of Oct 30vs prior close
- Market cap
- $185B
- P/E (TTM)
- 29.6×
- P/E (FY1)
- 19.2×
- Implied growth
- 12.5%
- From 52W high
- −16.66%
- EPS (LTM)
- $3.57
- Revenue (LTM)
- $45.1B
- Net margin
- 13.91%
- Dividend yield
- 2.37%
Nomior Score
51
Anchored CompounderTop 48% of the scored universe
Growth40
Quality74
Value61
Momentum21
Resilience61
Growth
+8.74%revenue a year over 9 fiscal years
YE16 $20.9BLTM $45.1B
Connections
Revenue to profitQ1 YE26
10% of revenue became net profit, down 3 pts on a year.
Who owns it
6funds, 8 tracked portfolios